163 related articles for article (PubMed ID: 36504325)
21. Aldehyde dehydrogenase 1A1 up-regulates stem cell markers in benzo[a]pyrene-induced malignant transformation of BEAS-2B cells.
Liu Y; Lu R; Gu J; Chen Y; Zhang X; Zhang L; Wu H; Hua W; Zeng J
Environ Toxicol Pharmacol; 2016 Jul; 45():241-50. PubMed ID: 27331345
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance.
Okudela K; Woo T; Mitsui H; Suzuki T; Tajiri M; Sakuma Y; Miyagi Y; Tateishi Y; Umeda S; Masuda M; Ohashi K
Int J Clin Exp Pathol; 2013; 6(1):1-12. PubMed ID: 23236537
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.
Wang Z; Wu J; Humphries B; Kondo K; Jiang Y; Shi X; Yang C
Toxicol Appl Pharmacol; 2018 Mar; 342():22-30. PubMed ID: 29391238
[TBL] [Abstract][Full Text] [Related]
25. Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.
Kim D; Dai J; Park YH; Fai LY; Wang L; Pratheeshkumar P; Son YO; Kondo K; Xu M; Luo J; Shi X; Zhang Z
J Biol Chem; 2016 Jul; 291(31):16271-81. PubMed ID: 27226640
[TBL] [Abstract][Full Text] [Related]
26. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
[TBL] [Abstract][Full Text] [Related]
27. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
28. TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.
Yu J; Alharbi A; Shan H; Hao Y; Snetsinger B; Rauh MJ; Yang X
Oncotarget; 2017 Jun; 8(24):38426-38443. PubMed ID: 28415606
[TBL] [Abstract][Full Text] [Related]
29. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
[TBL] [Abstract][Full Text] [Related]
30. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
31. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
[TBL] [Abstract][Full Text] [Related]
32. Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.
Dai J; Ji Y; Wang W; Kim D; Fai LY; Wang L; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2017 Sep; 331():164-173. PubMed ID: 28624442
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
[TBL] [Abstract][Full Text] [Related]
34. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
[TBL] [Abstract][Full Text] [Related]
35. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Li T; Su Y; Mei Y; Leng Q; Leng B; Liu Z; Stass SA; Jiang F
Lab Invest; 2010 Feb; 90(2):234-44. PubMed ID: 20010854
[TBL] [Abstract][Full Text] [Related]
36. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
37. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
[TBL] [Abstract][Full Text] [Related]
38. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
[TBL] [Abstract][Full Text] [Related]
39. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Chui MH; Wang Y; Wu RC; Seidman J; Kurman RJ; Wang TL; Shih IeM
Mod Pathol; 2015 Mar; 28(3):437-45. PubMed ID: 25216223
[TBL] [Abstract][Full Text] [Related]
40. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]